IRIS
CUSI, MARIA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.607
EU - Europa 10.672
AS - Asia 1.847
AF - Africa 84
SA - Sud America 35
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 19
Totale 24.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.554
GB - Regno Unito 2.593
IE - Irlanda 2.040
IT - Italia 1.505
CN - Cina 1.141
UA - Ucraina 976
SE - Svezia 966
RU - Federazione Russa 783
DE - Germania 604
FR - Francia 566
SG - Singapore 379
FI - Finlandia 366
VN - Vietnam 81
ES - Italia 71
CI - Costa d'Avorio 62
TR - Turchia 60
IN - India 55
BE - Belgio 50
CA - Canada 43
CZ - Repubblica Ceca 33
HK - Hong Kong 23
NL - Olanda 20
EU - Europa 19
AT - Austria 16
AU - Australia 16
BR - Brasile 14
JP - Giappone 13
BD - Bangladesh 11
PL - Polonia 10
IM - Isola di Man 9
IR - Iran 9
KR - Corea 9
CL - Cile 8
IQ - Iraq 8
RS - Serbia 8
PK - Pakistan 7
PT - Portogallo 7
SA - Arabia Saudita 7
CH - Svizzera 6
GH - Ghana 6
GR - Grecia 6
NZ - Nuova Zelanda 6
PH - Filippine 6
MT - Malta 5
PA - Panama 5
TH - Thailandia 5
ID - Indonesia 4
MW - Malawi 4
PE - Perù 4
SC - Seychelles 4
AM - Armenia 3
AR - Argentina 3
BG - Bulgaria 3
CY - Cipro 3
HU - Ungheria 3
IL - Israele 3
LU - Lussemburgo 3
MX - Messico 3
NO - Norvegia 3
RO - Romania 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AL - Albania 2
BZ - Belize 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
VE - Venezuela 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 24.286
Salva come PNG Salva come JPEG
Città #
Southend 2.342
Dublin 2.004
Fairfield 1.572
Chandler 1.146
Ashburn 907
Woodbridge 807
Jacksonville 787
Seattle 658
Wilmington 654
Houston 577
Cambridge 559
Ann Arbor 502
Siena 484
Santa Clara 359
Princeton 347
Nanjing 272
Singapore 268
Beijing 247
Menlo Park 244
Helsinki 186
New York 145
Boardman 131
San Mateo 116
Nanchang 100
San Diego 93
Moscow 87
Fremont 76
Munich 69
Dong Ket 67
Rome 64
Abidjan 62
Shanghai 61
Florence 59
Dearborn 57
Málaga 57
Shenyang 53
Hebei 52
Brussels 47
London 47
Izmir 45
Tianjin 45
Norwalk 41
Milan 40
Kunming 33
Lancaster 33
Jiaxing 31
Venezia 31
Los Angeles 30
Changsha 29
San Francisco 28
Toronto 27
Washington 24
Jinan 23
Lappeenranta 22
Redwood City 19
Padova 17
Auburn Hills 16
Guangzhou 16
Ningbo 16
Vienna 16
Frankfurt am Main 15
Düsseldorf 14
Hangzhou 14
Iesi 14
Zhengzhou 14
Brno 13
Dallas 12
Hong Kong 12
Taizhou 12
Hounslow 11
Lanzhou 11
Olomouc 10
Palermo 10
Cagliari 9
Espoo 9
Falls Church 9
Haikou 9
Hefei 9
Kilburn 9
Belgrade 8
Douglas 8
Edinburgh 8
Fuzhou 8
Mestre 8
Philadelphia 8
Pontedera 8
Prague 8
Hanoi 7
Madrid 7
Messina 7
Paris 7
Tokyo 7
Trieste 7
Amsterdam 6
Bari 6
Changchun 6
Chicago 6
Chittagong 6
Falkenstein 6
Groningen 6
Totale 17.311
Salva come PNG Salva come JPEG
Nome #
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 275
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 251
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 244
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 240
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 232
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 230
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 212
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 210
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 207
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 205
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 204
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 201
Peripheral biomarkers' panel for severe COVID-19 patients 194
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 188
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 188
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 184
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 179
HCMV infection in renal transplant recipients: a retrospective cohort study 176
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 176
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 176
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 175
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 175
Serological evidence of reinfection among vaccinees during rubella outbreak 170
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 167
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 162
Testicular involvement during Toscana-virus infection: an unusual manifestation? 160
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 160
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 157
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 156
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 156
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 154
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 153
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 152
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 152
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 151
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 151
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 149
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 148
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 147
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 144
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 144
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 144
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 143
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 143
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 141
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 139
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 138
Tumour associated antigen (TAA) specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes 137
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 136
Biotechnology for virus vaccine design, production, and control 135
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 135
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 133
Diagnostic tools for Toscana virus infection 131
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 131
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 129
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 128
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 128
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 127
Serial KL-6 measurements in COVID-19 patients 127
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 126
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 126
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 126
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 125
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 125
SARS-CoV-2 in pleural fluid in a kidney transplant patient 125
Synthetic peptides of rubella E1 glycoprotein for serological assays 124
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 122
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 122
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 122
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 121
Nucleotide variability of Toscana virus M segment in strains isolated from clinical cases 120
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. 120
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 119
Histological description of the lymphadenopathy related to Toscana virus infection. Report of a case 119
Applications of Influenza Virosomes as a delivery system 119
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 119
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 118
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 117
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them. 117
Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly 117
Development of a mouse model for the study of Toscana virus pathogenesis 115
A Mediterranean arbovirus: the Toscana virus 115
RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010 114
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 114
Rapid detection of different RNA respiratory virus species by multiplex RT-PCR: application to clinical specimens 114
In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse 113
Pathogenic mechanisms of Helicobacter pylori: production of cytotoxin. 113
Encephalitis without meningitis due to sandfly fever virus serotype toscana 113
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 113
In vitro generation of cytotoxic T lymphocytes against HLA-A2.1-restricted peptides derived from human thymidylate synthase 112
null 112
Bayesian skyline plot inference of the Toscana virus epidemic: a decline in the effective number of infections over the last 30 years 112
Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein 112
Editorial overview: Anti-infectives: Towards novel antiviral and antibacterial drugs? Current approaches to address a growing medical need 112
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 111
Toscana Virus Nucleoprotein” () 110
Potential of DNA vaccines delivered by influenza virosomes 110
Serological and molecular detection of Toscana and other Phleboviruses in patients and sandflies in Tunisia 110
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge 110
Infections in liver and lung transplant recipients: A national prospective cohort 110
Totale 14.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.623
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.623
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.623 0 0 0 0 273 307 379 572 347 370 101 274
2020/20213.802 159 409 108 345 236 543 192 508 441 289 281 291
2021/20222.647 167 276 145 214 128 89 128 143 222 285 252 598
2022/20234.170 260 334 523 554 417 844 84 355 433 104 171 91
2023/20243.179 112 108 268 184 104 835 1.090 76 18 77 68 239
2024/20251.986 184 362 564 348 528 0 0 0 0 0 0 0
Totale 24.688